• 27 Jan 26

Q&A with Venture Life CFO Danny Wells

Q&A with Venture Life CFO Danny Wells

Venture Life Group Plc | VLG | 66.5 -1.5 (0.0%)

    • 37 views

 

Following yesterday’s positive and in line FY’25 trading update, CFO Danny Wells of Venture Life - a leading consumer healthcare products firm - kindly takes me through the key drivers underpinning the double digit top line growth, Health & Her/Him brand, Performance overseas, expansion into US & outlook

Enjoying this article?

Get a £25 credit by sharing with your friends and colleagues via our Refer a Friend page. Each new subscriber gets a 10% discount and you get a free month off your bill every time.


Don't worry, if you're a Lite-Access/Free user we save all your credits for the day you decide to fully subscribe.


 

Q&A with Venture Life, CEO Jerry Randall

Companies: Venture Life Group Plc

Venture Life Group (VLG) Overview & investment case

Companies: Venture Life Group Plc

Venture Life Group (VLG) Capital Markets Day - 6th June 2023

Companies: Venture Life Group Plc

Venture Life Group (VLG) 2018 results

Companies: Venture Life Group Plc

Q&A with Venture Life, CEO Jerry Randall

Companies: Venture Life Group Plc

Venture Life reports strong order book and sales as demand for its hand sanitiser gel rockets

Companies: Venture Life Group Plc

© Research Tree 2026

  • Apple Store
  • Play Store

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top